Increased Risk of Type 2 Diabetes in Alzheimer Disease
Mayo Clinic · Mayo Clinic in Florida · +1 more institution
Abstract
Alzheimer disease and type 2 diabetes are characterized by increased prevalence with aging, a genetic predisposition, and comparable pathological features in the islet and brain (amyloid derived from amyloid beta protein in the brain in Alzheimer disease and islet amyloid derived from islet amyloid polypeptide in the pancreas in type 2 diabetes). Evidence is growing to link precursors of amyloid deposition in the brain and pancreas with the pathogenesis of Alzheimer disease and type 2 diabetes, respectively. Given these similarities, we questioned whether there may be a common underlying mechanism predisposing to islet and cerebral amyloid. To address this, we first examined the prevalence of type 2 diabetes…
Citation impact
- FWCI
- 7.70
- Percentile
- 100%
- References
- 79
Authors
6Topics & keywords
- Diabetes mellitus
- Medicine
- Type 2 diabetes
- Alzheimer's disease
- Disease
- Internal medicine
- Amyloid (mycology)
- Endocrinology
- Good health and well-being